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Abstract 
Metabolomics is a key approach in modern functional genomics and systems biology. 
Due to the complexity of metabolomics data, the variety of experimental designs, and 
the variety of existing bioinformatics tools, providing experimenters with a simple and 
efficient resource to conduct comprehensive and rigorous analysis of their data is of 
utmost importance. In 2014, we launched the Workflow4Metabolomics (W4M; 
http://workflow4metabolomics.org) online infrastructure for metabolomics built on the 
Galaxy environment, which offers user-friendly features to build and run data analysis 
workflows including preprocessing, statistical analysis, and annotation steps. Here we 
present the new W4M 3.0 release, which contains twice as many tools as the first 
version, and provides two features which are, to our knowledge, unique among online 
resources. First, data from the four major metabolomics technologies (i.e., LC-MS, 
FIA-MS, GC-MS, and NMR) can be analyzed on a single platform. By using three 
studies in human physiology, alga evolution, and animal toxicology, we demonstrate 
how the 40 available tools can be easily combined to address biological issues. 
Second, the full analysis (including the workflow, the parameter values, the input data 
and output results) can be referenced with a permanent digital object identifier (DOI). 
Publication of data analyses is of major importance for robust and reproducible 
science. Furthermore, the publicly shared workflows are of high-value for e-learning 
and training. The Workflow4Metabolomics 3.0 e-infrastructure thus not only offers a 
unique online environment for analysis of data from the main metabolomics 
technologies, but it is also the first reference repository for metabolomics workflows. 
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1. Introduction 
Metabolomics is the comprehensive quantification and characterization of the small 
molecules involved in metabolic chemical reactions (Oliver et al., 1998; Nicholson et 
al., 1999). It is a promising approach in functional genomics and systems biology for 
phenotype characterization and biomarker discovery, and has been applied to 
agriculture, biotechnology, microbiology, environment, nutrition, and health (Holmes 
et al., 2008; Chen et al., 2012; Rolin, 2013; Kell and Oliver, 2016; Johnson et al., 
2016). Complementary analytical approaches, such as Nuclear Magnetic Resonance 
(NMR) or High-Resolution Mass Spectrometry (HRMS) coupled to Liquid 
Chromatography (LC) or Gas Chromatography (GC), can be used after minimal 
sample preparation. These technologies allow routine detection of hundreds to 
thousands of signals in a variety of biological samples such as cell cultures, organs, 
biofluids, or biopsies (Cuperlovic-Culf et al., 2010; Brown et al., 2012). Due to the high 
complexity and large amount of signals generated, however, data analysis remains a 
major challenge for high-throughput metabolomics (Johnson et al., 2015).  
 
Analysis of metabolomics data (i.e., computational metabolomics) can be divided into 
three steps: preprocessing of raw data to generate the sample by variable matrix of 
intensities, statistical analysis to detect variables of interest and build prediction 
models, and annotation of variables to provide insight into their chemical and biological 
functions (Fig. 1). The two latter steps (statistics and annotation) can also be 
performed in the reverse order to get a first-pass overview of the dataset content by 
performing automatic query of metabolite databases. Furthermore, each step is 
subdivided into multiple successive, or alternative tasks. For example, preprocessing 
includes peak detection, denoising, and alignment. Statistical analysis involves 
normalization, univariate hypothesis testing and multivariate modeling. Finally, 
annotation relies on peak or spectrum matching with in-house and public databases 
of metabolites and spectra. This results in a high number of possible combinations of 
individual tasks to analyze in a dedicated data set. In addition, new methods and 
software tools constantly emerge to further expand, or refine, metabolomics analysis. 
Each of them has specific parameters and installation requirements. Typical data 
analysis by successive use of various software is time-consuming, repetitive, and 
error-prone: switching from one software to the other requires multiple steps of data 
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manipulation (import/export, up/download, format conversion). Additionally, the 
workflow (i.e., the sequence of software tools and the parameter values) is not saved, 
thus preventing efficient and reproducible analysis. 
 
Fig. 1. The Workflow4Metabolomics 3.0 online infrastructure (e-infrastructure) for data 
analysis of metabolomics experiments. Metabolomics experiments start with the biological 
question to be addressed, which, in turn, defines the experimental design. Sample collection, 
preparation, and analysis with NMR or MS instruments are then performed with the 
appropriate quality controls (reagent blanks, sample pools, etc.). The preprocessing step 
generates the sample by variable matrix of peak intensities. Statistical analysis includes 
normalization and batch-effect correction, univariate hypothesis testing, multivariate modeling, 
and feature selection. Annotation relies on the query of compounds and spectral databases, 
such as KEGG (Kanehisa and Gotto, 2000) and HMDB (Wishart et al., 2007). Identified 
metabolites can then be linked within genome-scale reconstructed networks, such as 
MetExplore (Cottret et al., 2010). More than 40 modules (tools) are currently available on the 
Workflow4Metabolomics e-infrastructure for building comprehensive LC-MS, FIA-MS, GC-
MS, and NMR preprocessing, statistical analysis, and metabolite annotation (Table 1). 
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Workflow management systems are software tools to compose and execute a series 
of computational tasks in a reproducible way (Leipzig, 2017). In the last decade, 
software environments with user-friendly features for creating, running, and sharing 
workflows have been developed, such as Galaxy (Giardine et al., 2005), Taverna (Hull 
et al., 2006), or KNIME (Berthold et al., 2006). Their graphical interfaces enable users 
who are not familiar with programming to build their workflow, by selecting tools and 
their parameters, and chain them in the desired order. Experimenters can therefore 
concentrate on the scientific design of the analysis and the interpretation of results, 
without worrying about software installation, command lines, scripts, data format and 
data management. 
 
 
Fig. 2. Galaxy features to create workflows on the W4M e-infrastructure. Selected 
computational tools (left panel), with the specific parameters values (right panel), can be 
chained to build the workflow (middle panel). Alternatively, workflows can be directly extracted 
from the current history by selecting Extract workflow from the History options menu. 
 
Galaxy is a major environment for workflow management available through a classic 
web-browser, with more than 50,000 users worldwide and hundreds of tools available 
(Boekel et al., 2015). The project started in the genomic community (Giardine et al., 
2005; Goecks et al., 2010), and further expanded to other omics fields such as 
proteomics (Boekel et al., 2015; Jagtap et al., 2014; Jagtap et al., 2015). The Galaxy 
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environment provides intuitive and powerful features that enable the experimenter to 
build and run complex workflows. For example, a tool can be re-run after changing a 
single parameter value with only two mouse clicks. The workflow (chained tools + 
selected parameter values) can be designed within a graphical editor interface (named 
canvas; Goecks et al., 2010; Fig. 2), and then run on the input data to obtain a history 
(workflow + attached input and output data). Alternatively, a history can be built by 
tuning the successive tools sequentially on the selected data set, and, once the history 
is completed, by extracting the corresponding workflow. A key feature is that both the 
workflow and the history can be saved and shared between users. 
 
To develop Galaxy pipelines for metabolomics, and make them available to the user 
community worldwide, we created the Workflow4Metabolomics online infrastructure 
(W4M e-infrastructure; Giacomoni et al., 2015). At that time, W4M already provided 
20 tools (some of them being newly developed for the infrastructure, while others 
corresponded to the integration of existing tools), which enabled the build of 
comprehensive workflows for LC-HRMS data analysis (Table 1). W4M not only gave 
access to the Galaxy environment to build workflows, but also offered a high-
performance computing environment to run the analyses, online documentations, and 
a help-desk served by 8 bioinformaticians from the Core Team. 
 
Here, we present the new 3.0 version of the W4M e-infrastructure. The 20 new tools 
(Table 1) enable advanced workflows not only for MS technologies (LC-MS, GC-MS 
and Flow Injection Analysis: FIA-MS) but also for NMR data. Furthermore, the 
complete histories can be referenced online with a permanent DOI, thus enabling fully 
reproducible analyses. To demonstrate how the new computational features from 
W4M 3.0 can be used to address biological issues, we selected three real LC-MS, GC-
MS, and NMR case studies from published studies in human physiology, mouse 
toxicology, and algae evolution. In the next section (Case Studies), we briefly recall 
the objective of the three studies and the analytical methods used to generate the raw 
data. In the Results section, we then create three workflows to analyze the data, and 
compare the outputs with the published results. 
 
 
  
9 
 
Table 1 
List of available tools on the W4M online infrastructure. The 20 new tools from the 3.0 release 
are indicated with (N). The source code of the W4M tools is available on the Galaxy toolshed 
(https://toolshed.g2.bx.psu.edu). 
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2. Case Studies 
We have selected three case studies which illustrate the diversity of the biological 
issues, experimental designs, and analytical technologies in metabolomics. Here, we 
briefly describe the context, objective, and analytical methods of these three published 
studies. 
2.1. Sacurine human physiological study (LC-HRMS) 
Human urine has been used since Antiquity for disease prediction. Nowadays, this 
biofluid shows great promise for biomarker discovery in metabolomics. 
Characterization of the variations of the urine metabolome with age, BMI, and gender, 
is therefore critical not only to better understand human physiology, but also to avoid 
confounding effects in biomarker studies. Since physiological information about urine 
concentrations is scarce in metabolomics databases, a cohort of 184 volunteers from 
the CEA research institute was studied (Roux et al., 2012; Thevenot et al., 2015). 
Urine samples were analyzed by Ultra-high Performance Liquid Chromatography 
(Hypersil GOLD C18 column) coupled to High-Resolution Mass Spectrometry (LTQ-
Orbitrap Discovery, Thermo Fisher Scientific). 
 
The work by Roux et al. (2012) focused on the identification of the metabolites in urine, 
while the second study (Thevenot et al., 2015) analyzed the variations of their 
concentrations with age, body mass index (BMI), and gender. Raw data were 
preprocessed with XCMS (Smith et al., 2006) and annotated with CAMERA (Kuhl et 
al., 2012), and a selection of metabolites of putative interest were identified at levels 1 
and 2 (Metabolomics Standard Initiative; Sumner et al., 2007) by matching with the 
KEGG (Kanehisa and Gotto, 2000), HMDB (Wishart et al., 2007) and METLIN (Smith 
et al., 2005) databases, followed by interpretation of additional MS/MS fragmentation 
experiments (Roux et al., 2012). Quantification of their intensities was refined by visual 
determination of the peak limits in the raw data (Quan Browser tool from the Xcalibur 
software; Thevenot et al., 2015). 
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The raw files, both in the proprietary (RAW; profile) and in the open (mzML; centroid) 
formats, are publicly available (MTBLS404) from the MetaboLights repository (Haug 
et al., 2013).  
2.2. Ectocarpus (brown algae) ecological study (GC-MS) 
The brown alga Ectocarpus (Ectocarpales, Phaeophyceae) is a rare example of 
freshwater colonization by a marine species. To understand the molecular 
mechanisms involved in the transition between these habitats, a freshwater strain 
(FWS, accession CCAP 1310/196, origin Hopkins River Falls, Victoria, Australia) was 
exposed to either medium (1.6 parts per thousand of medium, ppt) or seawater (32 
ppt) salinity, and compared with the genome-sequenced Sea Water strain (SWS, 
accession CCAP 1310/4, origin San Juan de Marcona, Peru) cultured in seawater 
medium only (Dittami et al., 2012). 
 
Metabolites profiles were analyzed by Gas Chromatography coupled to Mass 
Spectrometry (GC-MS): algal samples were first harvested by filtration 2 h after the 
beginning of the light phase; samples (50 mg) were then dried with a paper towel and 
ground in liquid nitrogen; finally, algal powder was extracted with methanol, and ribitol 
(200 µM) was added as an internal standard. The complete extraction procedure, 
derivatization steps, and chromatographic conditions are described in Dittami et al. 
(2011). 
2.3. Bisphenol A Mus musculus toxicological study (NMR) 
The aim of this study was to assess the effect of perinatal exposure to Bisphenol A 
(BPA) on the brain metabolome (Cabaton et al., 2013). Brain samples were collected 
on 21-days-old male mice, whose mothers were exposed to either 0.025 or 0.25 µg 
BPA/kg body weight/day during gestation and lactation. Twenty four aqueous extracts 
(11 extracts from mice exposed to 0.025 µg and 13 from mice exposed to 0.25 µg) 
were analyzed on a Bruker DRX-600-Avance NMR spectrometer operating at 600.13 
MHz for 1H resonance frequency using an inverse detection 5 mm 1H-13C-15N 
cryoprobe attached to a CryoPlatform (the preamplifier cooling unit). The 1H NMR 
spectra were acquired at 300 K using the Carr-Purcell-Meiboom-Gill (CPMG) spin-
echo pulse sequence with pre-saturation, with a total spin-echo delay (2nτ) of 100 ms 
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to attenuate broad signals from proteins and lipoproteins. A total of 128 transients were 
collected resulting in 32,000 data points using a spectral width of 12 ppm, a relaxation 
delay of 2.5 s and an acquisition time of 2.28 s. Prior to Fourier Transformation, an 
exponential line broadening function of 0.3 Hz was applied to the FID. All NMR spectra 
were phased and baseline corrected with the TopSpin software (Bruker). 
3. Results 
The Workflow4Metabolomics online infrastructure (W4M e-infrastructure) offers a 
user-friendly and computationally efficient environment to build, run, and share 
workflows (see the Workflow Management with W4M section in the supplementary 
material). The W4M 3.0 release provides a total of 40 tools, from preprocessing, 
through statistical analysis, and up to annotation, including 20 new modules for 
advanced LC-HRMS analysis, FIA-MS, GC-MS and NMR workflows (Table 1). 
3.1. Analysis of LC-MS, GC-MS, and NMR metabolomics 
data sets on W4M 
To demonstrate how the tools can be combined on W4M to address biological issues, 
we designed three computational workflows to analyze data sets from published 
studies in human (Thevenot et al., 2015), algae (Dittami et al., 2012), and mouse 
(Cabaton et al., 2013). 
3.1.1. Physiological variations of the human urine metabolome: The 
W4M00001_Sacurine-statistics and W4M00002_Sacurine-
comprehensive LC-HRMS histories 
To characterize the physiological variations of the human urine metabolome with age, 
body mass index (BMI), and gender, samples from a cohort of adult volunteers from 
the Saclay research institute (hence the “sac[lay]urine” name) have been analyzed by 
LC-HRMS (Thevenot et al., 2015). 
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To investigate how the statistical analysis from the published study could be performed 
on W4M, the Sacurine-statistics workflow was first built with the following steps (Fig. 
3 and statistical steps from the supplementary Table S1): 
1. Batch correction: Correction of the signal drift by local regression (loess) 
modeling of the intensity trend in pool samples (Dunn et al., 2011); Adjustment 
of offset differences between the two analytical batches by using the average 
of the pool intensities in each batch (van der Kloet et al., 2009) 
2. Quality Metrics: Variable quality control by discarding features with a 
coefficient of variation above 30% in pool samples 
3. Normalization: Intensity normalization by sample osmolality 
4. Transformation: Log10 transformation 
5. Quality Metrics: Sample outlier filtering by using three statistics: Weighted 
Hotellings’T2 distance (Tenenhaus et al., 1999), Z-score of one of the intensity 
distribution deciles (Alonso et al., 2011), and Z-score of the number of missing 
values (Alonso et al., 2011) 
6. Univariate: Non-parametric univariate hypothesis testing of Spearman 
correlation with age or BMI, and of difference between gender medians 
7. Multivariate: Multivariate modeling by Orthogonal Partial Least Squares 
(OPLS) of the age, BMI, and gender responses 
8. Heatmap: Visualization of sample and variable clusters (by using the 1 - cor 
dissimilarity, where cor is the Spearman correlation) 
 
The workflow consists of 18 tools. Importantly, several of these computational 
methods are available online only on W4M. In addition, the statistical tools are generic 
(except the first one, Batch correction, which is focused on LC-MS data), and can 
thus be applied to any omic data set. 
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Fig. 3. Overview of the W4M00001 Sacurine-statistics and W4M00002 Sacurine-
comprehensive workflows (DOI:10.15454/1.4811121736910142E12 and 
DOI:10.15454/1.481114233733302E12). The input data (184 samples, 26 QC pools, and 24 
reagent blanks) were acquired in the negative ionization mode, in two batches (117 samples 
each). Note that the same workflows can be applied to the data from the positive ionization 
mode, except that the polarity parameter must be switched in the annotation tools (i.e., 
CAMERA, KEGG, and HMDB). The raw data are publicly available in the MetaboLights 
repository (MTBLS404). 
 
The workflow was applied to the preprocessed table of peak intensities from 210 
samples (184 urine of volunteers + 26 injection of the QC pool) and 113 identified 
metabolites from the negative ionization mode (see the Case Studies section for the 
description of the study, and the Workflow Management with W4M section for the 
formats of the dataMatrix.tsv, sampleMetadata.tsv, and variableMetadata.tsv input 
files). The running time on W4M was only a few minutes and the resulting history 
contained 53 files (total size: 4.0 MB). Statistical results were identical to those from 
the publication by Thevenot et al. (2015). In particular, the peak table used for 
univariate and multivariate statistics contained 183 samples and 109 metabolites, 
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since the quality control steps discarded the HU_096 sample (p-values of the 
Hotelling’s T2 and decile Z-score < 10-4) and 4 variables (coefficient of variation in QC 
injections > 30%). This peak table is also identical to the data set included in the ropls 
Bioconductor package (Thevenot et al., 2015). The Sacurine-statistics history was 
publicly shared on the W4M e-infrastructure. It was assigned the W4M00001 reference 
ID and the permanent DOI:10.15454/1.4811121736910142E12 Digital Object 
Identifier (DOI) link for permanent access and citation (see the Referencing Histories 
section below). 
 
To perform the full analysis of the sacurine dataset (i.e., not restricting the analysis to 
the statistical steps nor to the identified metabolites only), we designed the Sacurine-
comprehensive workflow, starting with the preprocessing of the raw files, then 
performing the statistical analysis and finally annotating the full peak table (Fig. 3A): 
1. xcms.xcmsSet, xcms.group, xcms.retcor, and xcms.fillPeaks: 
Preprocessing of the raw files with XCMS (Smith et al., 2006) 
2. CAMERA.annotate: Annotation of isotopes, adducts and fragments with 
CAMERA (Kuhl et al., 2012) 
3. Statistical analysis (identical to the Sacurine-statistics workflow, with the 
addition of the Biosigner tool) 
4. HMDB MS search and Kegg Compounds: Annotation by m/z matching to the 
HMDB (Wishart et al., 2007) and KEGG (Kanehisa and Goto, 2000) metabolite 
databases;  
 
The Sacurine-comprehensive workflow includes 29 tools (21 being unique; Table S1) 
and provides a comprehensive example of the analysis of LC-HRMS metabolomics 
data (Fig. 3). In the statistical section, the Biosigner tool (Rinaudo et al., 2016) was 
included to further identify significant molecular signatures for classification between 
genders (see below). 
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Fig. 4. Results from the W4M00002_sacurine-comprehensive history 
(DOI:10.15454/1.481114233733302E12). (A) Computation time of the full analysis. Only tools 
running for more than 15 min are labeled. The total running time of the whole history (29 tools) 
was 10:10 hours. (B) Significant metabolite signatures for the discrimination between genders 
by each of the three PLS-DA, Random Forest, and Support Vector Machine (SVM) classifiers 
were selected independently with the Biosigner tool (Rinaudo et al., 2016). The biosigner 
algorithm iteratively selects only the features whose random permutation in the test subset 
decrease the prediction performances (Rinaudo et al., 2016). The metabolites from the final 
signature (i.e., those which passed all the selection iterations) are indicated in the 
corresponding classifier column with a dark green color. Metabolites which were discarded 
during one of the previous rounds are indicated with a color gradient from light green to dark 
red (by decreasing number of selection rounds). Dashed (respectively, dotted) borders around 
metabolite names indicate the 13C isotope (respectively, the Pantothenic acid dimer). 
 
The 234 raw files (184 samples + 26 injections of the Quality Control pool + 24 blanks) 
in mzML format (centroid mode) were split into two subfolders (one “blank” directory 
containing the blank reagent files only, and one “bio” directory with the remaining 210 
human and pool samples), before uploading as a single zipped file (17.6 GB). 
Application of the Sacurine-comprehensive workflow to this dataset resulted in a 
history containing 94 files, after a running time of about 10 hours (Fig. 4A). The majority 
of the time was spent in preprocessing with the XCMS tools and, to a lesser extent, in 
annotation with CAMERA.annotate, as these algorithms work on the raw files. In the 
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statistical section, the Biosigner tool required 22 min of computation time, due to the 
large number of models built during the internal bootstrapping approach (Fig. 4A). 
 
The preprocessing step with the XCMS tools and the original parameter values (Roux 
et al., 2012) generated a peak table (dataMatrix) containing 4,667 features (Table S1), 
including 342 ions previously described in urine (Roux et al., 2012). These results were 
comparable with the 4,114 features (including 334 characterized ions) from the original 
peak table obtained at the time of the publication by Roux et al. (2012). We further 
evaluated the centWave algorithm which has been shown to provide better peak 
detection on high-resolution data sets compared with the original matchedFilter 
method (Tautenhahn et al., 2008). Such a comparison is straightforward on W4M due 
to both features provided by Galaxy for modifying only a few parameter values (in the 
xcms.xcmsSet tool) and re-running the workflow, and the high-performance 
environment of the infrastructure. A higher number of variables of interest (372 of the 
previously characterized metabolites in urine) were detected by centWave, with the 
parameter values suggested for an UPLC/Orbitrap acquisition system (Patti et al., 
2012). The total size of the peak table after the quality control filtering steps (which 
discard the ions with concentrations less than twice the concentration in blank reagent 
samples, or with a coefficient of variation in pool samples superior to 30% after signal 
drift correction) was also higher (3,120 features), including 85% of the matchedFilter 
ions. The centWave method was therefore selected for the reference workflow and 
history described hereafter (Table S1). 
 
As the identification of molecular signatures for prediction is of high interest in 
biomarker studies, the Biosigner tool was added to the statistical section of the 
workflow. Biosigner selects features that are significant for the predictive performance 
of either a PLS-DA, a Random Forest, or a Support Vector Machine classifier (Rinaudo 
et al., 2016). Eight features were selected in at least one of the molecular signatures, 
including one 13C isotopes and one dimer (Fig. 4B). The PLS-DA, Random Forest, and 
Support Vector Machine trained on each selected signatures (containing less than 0.2 
% of the initial variables) achieved high classification performances (84%, 90%, and 
92%, respectively). Three variables, which were annotated by the KEGG query and 
also matched the characterized metabolites described in urine (Roux et al., 2012), had 
been selected previously by Biosigner on the restricted dataset from the 
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W4M00001_Sacurine-statistics history (Rinaudo et al., 2016): Testosterone 
glucuronide, p-Anisic Acid (or 4-Methoxybenzoic acid), and Oxoglutaric acid (or alpha-
Ketoglutaric acid). This confirms that results could be reproduced on W4M using a 
comprehensive workflow starting from the raw files. It also highlights 4 additional ions 
providing high classification performance (including M479.2275T434) that were not 
previously described in the urine metabolome. 
3.1.2. Evolutionary mechanisms involved in the adaptation of marine 
species to freshwater: The W4M00004 GCMS Algae history 
Colonization of freshwater by marine organisms, as observed in Ectocarpus (brown 
algae), is a rare event. To understand the mechanisms involved in such an adaptation, 
a Fresh Water Strain (FWS) cultured in either low or seawater salinity, and a Sea 
Water Strain (SWS), were studied at several molecular levels, including metabolomics 
by GC-MS analysis (Dittami et al., 2012). At the time of the publication by Dittami and 
colleagues, no GC-MS tool was available on W4M. To reproduce the study results, we 
therefore implemented two new Galaxy tools for preprocessing and annotation (since 
the statistical tools already available on W4M can be applied to data from all 
technologies). First, the metaMS.runGC tool based on the metaMS package from 
Wehrens et al. (2014) was integrated for preprocessing. The main parameter is FWHM 
(full width at half maximum of chromatographic peaks), which is used for peak picking 
by the internal call to the matchedFilter algorithm from XCMS (Smith et al., 2006). The 
default value is 5 s, and can be modified within the User_defined setting. The 
metaMS.runGC function further groups individual ions within the same retention time 
window and same chromatographic profile into pseudospectra, by using the 
groupFWHM function from CAMERA (Kuhl et al., 2012). Each pseudospectrum 
usually (but not always) contains ions originating from a single compound (Wehrens 
et al., 2014). Finally, annotation information is added by matching pseudospectra 
against each other (or, optionally, against a database of standards with the Use 
Personal Database option). A table of retention index (RI) of each alkane used in the 
GC-MS experiment can also be provided (Use RI option): with that option, the RI 
information is added into the variableMetadata.tsv outputs, which can facilitate peak 
annotation. The main output of metaMS.runGC is a data matrix of pseudospectra 
intensities (sum of the intensities of all ions from the pseudospectrum), which can be 
19 
 
used for downstream statistical analysis. It is important to note that, in this data matrix, 
each row corresponds to one compound, in contrast to the classical XCMS output 
where each row is a single ion feature. This is particularly interesting because unlike 
electrospray ionization commonly used in LC-MS, electron impact ionization in GC-
MS generates a lot of ions for each compound. 
 
 
Fig. 5. W4M00004 GCMS Algae reference workflow 
(DOI:10.15454/1.4811272313071519E12). Twelve Ectocarpus samples (brown algae), 
corresponding to 4 biological replicates of 3 algal cultures (a freshwater strain in low and 
seawater saline conditions, and a marine strain as a control) were analyzed with an Agilent 
GC-MS instrument. Preprocessing, statistics, and annotation of the data set were performed 
with the metaMS.runGC, Multivariate, and Golm Metabolome Database tools, in addition 
to a local query of the NIST database (Table S2). An in-house spectral database was created 
and used to refine the peak picking (red arrow). Raw files (in the open NetCDF format) are 
publicly available on W4M (http://workflow4metabolomics.org/datasets). 
 
Second, we developed a tool to search the Golm Metabolome Database (Kopka et 
al., 2005). This annotation tool uses the peakspectra.msp file generated by 
metaMS.runGC. The .msp file can be further exported to query the commercial NIST 
database with the mssearch software (usually installed on GC-MS instruments). The 
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resulting .msp file can be used as an in-house database (Wehrens et al., 2014) to 
annotate pseudospectra from future experiments. 
 
To perform the analysis of the GC-MS data from the three Ectocarpus cultures (a 
freshwater strain in low and seawater saline conditions, and a marine strain as a 
control), the W4M00004 GCMS Algae workflow was then designed (Fig. 5 and Table 
S2): 
1. Preprocessing with metaMS.runGC (the default parameter values were used) 
2. Annotation by using the Golm Metabolome Database tool and the local NIST 
database 
3. Creation of a spectral database with identified pseudospectra 
4. metaMS.runGC: Reprocessing using the in-house database for refined 
pseudospectra alignment 
5. Normalization: Intensity normalization by dry weight of sample 
6. Multivariate: Exploratory data analysis with PCA 
7. Multivariate: PLS-DA modeling of the three distinct algal cultures 
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Fig. 6. Quality control and annotation of the “Unknown 2” pseudospectrum. Top: The EIC of 
the pseudospectrum clearly indicates that all grouped ions belong to a single compound (no 
co-elution). Only ions with correlated chromatographic profiles are grouped by the metaMS 
algorithm, resulting in a cleaned pseudospectrum for further spectral database annotation 
(Wehrens et al., 2014). Bottom: After matching to the Golm and NIST databases, the 
“Unknown 2” pseudospectrum was annotated as citric acid, which is the correct identification 
(confirmed by injection of the pure compound).  
 
Prior to data upload, the 12 GC-MS raw files (4 biological replicates of the 3 cultures) 
were converted from the Agilent commercial format (*.D) into the open NetCDF format, 
by using the Agilent Chemstation software (‘export as AIA/ANDI Files’ menu; Note that 
the freely available ProteoWizard software can also be used for file conversion; 
Chambers et al., 2012). The converted files from the W4M00004 study are available 
for download from W4M as a unique zipped file (260.8 MB; 
http://workflow4metabolomics.org/datasets). 
 
Application of the workflow to the raw data resulted in a history containing 21 files 
generated in 11 minutes (7 min for peak picking and 4 min for statistics). The data 
matrix contained 52 pseudospectra. The quality of each pseudospectrum was checked 
visually on the GCMS_EIC.pdf output (Fig. 6, top). All pseudospectra were then 
matched against the Golm and NIST spectral databases, by using the 
peakspectra.msp file (Fig. 6, bottom). As a control, the internal standard ribitol was 
confirmed to be the “Unknown 5”. Importantly, “Unknown 2” and “Unknown 4” were 
annotated as citric acid and mannitol, respectively (Fig. 6, bottom). Surprisingly, 
mannitol was not detected in two samples (alg 2 and alg 3), because the retention time 
shift (15 s) was superior to the default threshold in metaMS.runGC (3 s). We therefore 
used an option from metaMS.runGC which enables to refine the alignment of 
pseudospectra between samples by providing a database of reference spectra 
(Wehrens et al., 2014): first, we created a spectral database with ribitol, citric acid, and 
mannitol, from the peakspectra.msp file generated previously; second, we re-run the 
metaMS.runGC tool with this additional spectral information, and successfully 
detected mannitol in all samples (feedback step on Fig. 5). We could then perform the 
downstream statistical analyses. The matrix of intensities (dataMatrix) was first 
normalized by dry weight of sample. Exploratory data analysis was then performed by 
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PCA: distinct clusters corresponding to three algal cultures were observed on the 
score plot. In particular, a clear metabolic shift was observed for the FWS cultures 
from the low versus seawater saline conditions. The decreased concentrations of 
mannitol, which is a putative osmoprotector, in the FS strain, were in accordance with 
the results from Dittami et al. (2012). Finally, PLS-DA discrimination between the 3 
cultures resulted in a classifier with a significant (p < 0.05, when compared with models 
built after random permutation of the labels) and high Q2 value (Q2Y = 0.84). These 
multivariate analyses, which were not included in the original publication, therefore 
provide complementary information. 
3.1.3. Brain toxicity of Bisphenol A: The W4M00006 NMR 
BPAMmusculus history 
The aim of this study was to assess the effect on the brain metabolome of perinatal 
exposure to Bisphenol A (BPA), an endocrine disruptor widely used in plastics and 
resins (Cabaton et al. 2013). To analyze NMR data on W4M, specific preprocessing 
and annotation modules have been developed for the 3.0 version (see below). The 
implemented workflow (Fig. 7) corresponds to a complementary pairwise comparison 
study (BPA0.025 vs BPA0.25), which was not presented in the original publication. 
The 0.25 and 0.025 µg BPA/kg body weight/day treatments correspond to 1/100 and 
1/000 of the tolerable daily intake (TDI: “Estimated maximum amount of an agent, 
expressed on a body mass basis, to which individuals may be exposed daily over their 
lifetimes without appreciable health risk”; World Health Organization, 2004) and were 
picked up to demonstrate that even at very low doses of exposure, BPA is still 
modulating differently the brain metabolome of the CD1 mice. 
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Fig. 7. W4M00006 BPAMmusculus reference workflow 
(DOI:10.15454/1.4821558812795176E12). The input data (24 samples) were acquired using 
1H NMR spectroscopy. TopSpin (Bruker) preprocessed files (Bruker format) are available on 
W4M for download (http://workflow4metabolomics.org/datasets). 
 
The 7 tools from the BPAMmusculus workflow are detailed in Table S3 and illustrated 
on Fig. 8. First, the 24 TopSpin-preprocessed spectra were uploaded into W4M as a 
single zipped file (see the Workflow Management with W4M section). Second, spectra 
were segmented into 809 buckets by using the NMR Bucketing tool: this tool divides 
the whole spectrum into “small” fixed-size windows (e.g., 0.01 ppm). In addition, 
spectrum regions corresponding to water, solvent or contaminant resonances can be 
excluded. Finally, the sum of intensities inside each bucket (area under the curve) is 
computed by using the trapezoidal method. Third, spectra were normalized to the Total 
Intensity with the NMR Normalization tool. The objective of sample normalization is 
to make the data from all samples directly comparable with each other (i.e., to remove 
systematic biological and technical variations). The NMR Normalization tool includes 
3 normalization methods: Total intensity (each bucket integration is divided by the 
integration of the total spectrum), quantitative variable (e.g., sample weight, 
osmolality), and Probabilistic Quotient Normalization (PQN; Dieterle et al., 2006), 
where each spectrum is compared to a reference sample (e.g., the median spectrum 
of control samples). Fourth, exploratory data analysis and multivariate modeling were 
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performed with the Multivariate tool. PCA was first used to detect outliers: two 
observations were excluded for subsequent analyses. Then, an OPLS-DA classifier of 
the two treatment doses was built: the model was significant (permutation test p-value 
< 0.05), and 157 variables (buckets) having a VIP value > 0.8 were selected. In 
parallel, univariate analysis of differences between the two doses was performed with 
the Wilcoxon-Mann-Whitney test (Univariate tool). No significant difference was 
observed after correction for multiple testing (False Discovery Rate set to 5%). 
 
 
Fig. 8. W4M00006 BPAMmusculus: From experiment to metabolite annotation. Top: 
Experimental design, sample preparation, and acquisition of NMR spectra (Bruker files). (1-3) 
Data reduction (bucketing + normalization). (4) Multivariate analysis (PCA and OPLS-DA 
score plots, and permutation tests). (5-6) Annotation of significant metabolites. 
 
Sixth, buckets were annotated with the NMR Annotation tool. This tool decomposes 
any input spectrum from a complex biological matrix into a mixture of spectra from 
pure compounds provided as a reference database. The internal database currently 
contains 175 spectra of pure compounds, which were acquired on a Bruker Avance III 
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600 MHz NMR spectrometer, at pH 7.0. The deconvolution algorithm uses a penalized 
regression to compute a parsimonious list of non-zero coefficients (i.e., proportions) 
for the reference spectra detected in the mixture (Tardivel et al., submitted). The output 
proportionEstimation table contains the identified metabolites with their estimated 
relative concentration (the highest concentration being arbitrarily set to 1). The NMR 
Annotation tool was applied to one spectrum from each of the two classes (BPA0.025 
and BPA0.25), and resulted in the annotation of 39 metabolites. Among them, the 
Glutamic Acid and the GABA neurotransmitters had high VIP predictive values (4.1 for 
the 2.35 ppm bucket, and 2.6 for the 2.3 ppm bucket, respectively), which confirmed 
the previous results showing a decrease of the concentrations of these metabolites 
following exposure to BPA (Cabaton et al., 2013). Furthermore, these new analyses 
showed that two other neurotransmitters, Taurine (3.44-3.41, 3.26-3.24 ppm) and 
Aspartate (3.91-3.89, 2.7-2.69 ppm), had high discriminative values (VIP of 2.9 for the 
3.26 ppm bucket, and 2.2 for the 3.90 ppm bucket, respectively). To our knowledge, 
this is the first time that comprehensive NMR workflows (from preprocessing to 
identification) can be created, run, and published online. 
3.2. Referencing histories 
The histories from each case study (i.e., workflow and the associated input data and 
output result files) were further published on W4M (i.e., shared with the community) 
and referenced with a digital object identifier (DOI) which can be cited in publications 
(Table 2). Referenced histories can be imported by any user into his/her account, and 
the workflow can be extracted from the history with the Extract Workflow functionality, 
e.g., for application to new data sets. 
 
Making workflows and associated data available to the community is essential to 
demonstrate the value and the reproducibility of the analysis (Mons et al., 2011). As 
for raw data, journal editors will increasingly recommend that the process of generating 
the results (code, parameter values, output data) is made available on reference 
repositories. Funding agencies such as European Programs also require that the 
generated data are made public on reference online resources. Finally, sharing 
analyses gives experimenters the opportunity to receive feedback on their results, get 
cited, and initiate new collaborations. While databases for raw data and metabolites 
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already exist, the W4M e-infrastructure is the first repository for data analysis 
workflows dedicated to metabolomics. 
 
Referencing histories on W4M is straightforward (see the “Referenced Workflows and 
Histories” section on the home page). Authentication is required to access the shared 
histories in Galaxy. Extra anonymous credentials for reviewers, however, may be 
provided to authors from reference histories when submitting their manuscript. Six 
histories have already been referenced (Table 2), and have been cited in publications 
such as Thevenot et al. (2015), Rinaudo et al. (2016), and Peng et al. (2017).  
 
 
Table 2 
Publicly referenced histories (workflows and associated data and result files; 
http://workflow4metabolomics.org/referenced_W4M_histories). The DOI points to a landing 
page which details the main steps, data size, and name of the maintainer, and gives access 
the whole history online. 
ID Raw data Technol. Species Matrix Factor(s) Nb 
samples 
Size Publication 
W4M00001_
Sacurine-
statistics 
DOI:10.1545
4/1.4811121
736910142E
12 
MTBLS404 LC-MS H. sapiens urine age, BMI, 
gender 
210 4 
MB 
Thevenot et al., 
2015 
DOI:10.1021/acs.j
proteome.5b0035
4  
W4M00002_
Sacurine-
comprehensi
ve 
DOI:10.1545
4/1.4811142
33733302E1
2 
MTBLS404 LC-MS H. sapiens urine age, BMI, 
gender 
234 18 
GB 
Thevenot et al., 
2015 
DOI:10.1021/acs.j
proteome.5b0035
4  
W4M00003_
Diaplasma 
DOI:10.1545
4/1.4811165
052113186E
12 
N/A LC-MS H. sapiens plasma diabetic 
type 
63 11 
MB 
Rinaudo et al., 
2016 
DOI:10.3389/fmol
b.2016.00026 
W4M00004_
GCMS-Algae 
DOI:10.1545
4/1.4811272
313071519E
12  
N/A GC-MS E. 
siliculosus 
alga salinity 12 260 
MB 
Dittami et al., 
2012 
DOI:10.1111/j.136
5-
313X.2012.04982.
x 
W4M00005_
Ractopamine
-Pig 
DOI:10.1545
MTBLS384 LC-MS S. Scrofa serum Ractopami
ne 
164 327 
MB 
Peng et al., 2017 
DOI:10.1007/s113
06-017-1212-0 
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4/1.4811287
270056958E
12 
W4M00006_
BPA-
Mmusculus 
DOI:10.1545
4/1.4821558
812795176E
12 
W4M NMR Mus 
Musculus 
brain BPA dose 24 7 
MB 
Cabaton et al., 
2013 
DOI:10.1289/ehp.
1205588  
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4. Discussion 
High-throughput analysis of the metabolic phenotype has a profound impact on the 
understanding of biochemical reactions and physiology, and prediction of disease 
(Peyraud et al., 2011; Balog et al., 2013; Etalo et al., 2015; Li et al., 2016; Weiss et 
al., 2016). To cope with the volume and complexity of data generated by modern high-
resolution MS and NMR instruments, adapt to the diversity of experimental designs, 
and ensure rigorous and reproducible analyses, there is a strong need for user-
friendly, modular, and computationally efficient software platforms. To demonstrate 
how the Workflow4Metabolomics 3.0 e-infrastructure meets this workflow challenge, 
we designed, run, and referenced online three comprehensive analyses of previously 
published LC-MS, GC-MS, and NMR data studies from human physiology, mouse 
toxicology, and alga evolution. The workflow sequence, parameter values, and critical 
points are detailed to provide examples of critical design and interpretation of 
analyses. The outputs of W4M analyses confirmed the published results: for each case 
study, key metabolites were selected and annotated, with significant concentration 
differences either between gender, BMI, and age (human study), or after perinatal 
exposition to Bisphenol A (mouse study), or in response to salinity stress (algae study). 
Furthermore, they shed new lights on the datasets, e.g., by suggesting variations of 
neurotransmitter concentrations even at the lowest doses of BPA exposure (mouse 
study). Workflow building and running was very efficient: the Sacurine-comprehensive 
workflow, which contains 29 tools for preprocessing, statistical analysis and 
annotation, could be run on 234 raw files in a few hours. Workflow management was 
straightforward, as illustrated by the comparison between the matchedFilter and 
centWave approaches for LC-MS preprocessing. Together, these results demonstrate 
that comprehensive LC-MS, GC-MS, and NMR data analyses can be readily designed 
and run on the W4M e-infrastructure. 
 
The number of available tools on W4M 3.0 for pre-processing, statistical analysis and 
annotation, 40, has doubled since the previous release (Giacomoni et al., 2015), and 
now allows to analyze LC-MS, FIA-MS, GC-MS, and NMR data. Importantly, several 
tools implement original methods from the Core Team which provide unique features 
to the W4M workflows, such as the Biosigner tool for selection of significant molecular 
signatures for PLS-DA, Random Forest, or SVM classifiers, the NMR Annotation tool 
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for annotation of NMR spectra, or the proFIA tool for the preprocessing of data from 
Flow Injection Analysis coupled to High-Resolution Mass Spectrometry (FIA-HRMS; 
Delabriere et al., under review). Furthermore, to cope with the computer intensive 
preprocessing of LC-MS data, the xcms.xcmsSet and CAMERA.annotate tools can 
now be run in parallel (see the supplementary material). All W4M tools are 
implemented by a large core team of bioinformaticians and biostatisticians based on 
five metabolomics facilities, and supported in the long term by two national 
infrastructures, namely the French Institute of Bioinformatics (IFB; French Elixir node) 
and the National Infrastructure for Metabolomics and Fluxomics (MetaboHUB). In 
addition to ensuring a sustainability and high-performance computing environment, 
these large clusters provide cutting-edge technologies, know-how, and scientific 
expertise from both the experimental and computational fields. In the near future, new 
unique tools will be available on W4M (e.g., to extend the NMR workflow and to 
analyze MS/MS data). Moreover, complementary Galaxy tools have been recently 
described in metabolomics (e.g., for Direct Infusion MS data; Davidson et al., 2016), 
but also in complementary omics communities (Boekel et al., 2015) such as 
proteomics (Jagtap et al., 2015; Jagtap et al., 2014; Fan et al., 2015). Due to the 
modularity of the Galaxy environment, and the relative ease of wrapping existing code 
into Galaxy tools, the number of W4M tools and contributors should continue to expand 
rapidly. To help developers integrating their tools, an updated virtual machine and the 
code of the Galaxy modules are publicly available on the W4M GitHub 
(https://github.com/workflow4metabolomics) and the Galaxy Toolshed 
(https://toolshed.g2.bx.psu.edu/; ‘[W4M]’ tag) repositories. 
 
Workflow4Metabolomics brings the workflow management features of the Galaxy 
environment to the metabolomics user community through its online infrastructure. 
Online availability has many advantages compared with local installation: no local 
computing resources are needed, local software installation and update is not 
required, and the infrastructure can be directly accessed from anywhere. Two online 
platforms have recently emerged for LC-MS processing and annotation (XCMS 
Online; Tautenhahn et al., 2012), and statistical analysis (MetaboAnalyst; Xia et al., 
2009), respectively. In contrast, W4M provides for the first time a single resource for 
the comprehensive analysis of either LC-MS, FIA-MS, GC-MS, or NMR metabolomics 
data. In addition, by building on the Galaxy environment, W4M provides the user with 
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unique features to build, run, and share workflows and histories (e.g., with remote 
collaborators in multi-center or transdisciplinary projects). 
 
In particular, W4M 3.0 now offers to reference a history publicly, by assigning a unique 
ID and DOI permanent link, which can be cited in publications. To our knowledge, this 
is the first time that workflows (and associated data) can be referenced. Furthermore, 
since the source code of the W4M tools is also publicly available (as discussed above), 
referenced analyses can be fully dissected and reproduced online (or locally) by the 
scientific community. The W4M infrastructure thus fills a gap between existing 
repositories for raw data, such as MetaboLights (Haug et al., 2013) or the 
Metabolomics Workbench (Sud et al., 2016), and the spectral and metabolite 
databases such as KEGG (Kanehisa and Goto, 2000), HMDB (Wishart et al., 2007), 
ChEBI (Degtyarenko et al., 2008) or MassBank (Horai et al., 2010). Further 
interoperability between the W4M workflow resource and the MetaboLights data 
repository is ongoing within the PhenoMeNal European consortium. In the open data 
era (Leonelli et al., 2013), the need for peer-reproduced workflows (Gonzalez-Beltran 
et al., 2015) and workflow storage (Belhajjame et al., 2015) is pivotal for good science 
and robust transfer to the clinic (Baker, 2005). Besides, funding agencies and journal 
editors already require data to be made publicly available (the MetaboLights repository 
is already recommended by scientific journals such as Metabolomics, the EMBO 
Journal, and Nature Scientific Data; Kale et al., 2016). W4M should therefore become 
the reference repository for metabolomics workflows.  
 
To help users cope with data analysis concepts, parameter tuning, and critical 
interpretation of diagnostics and results, training is of major importance (Via et al., 
2013; Weber et al., 2015). On the W4M infrastructure, remote e-learning is possible 
through many tutorials (http://workflow4metabolomics.org/howto). In addition, the 
reference histories provide detailed examples of workflows, and of table and figure 
outputs (http://workflow4metabolomics.org/referenced_W4M_histories). Furthermore, 
“hands-on” sessions using W4M can be readily organized since only an internet 
connection is needed to access the infrastructure (for users wishing to use W4M for 
training, please contact us at contact@workflow4metabolomics.org). Based on our 
experience, optimal results are achieved when users analyze their own data. We 
therefore regularly organize one-week courses combining practical presentations in 
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the mornings, and tutoring sessions in the afternoons (Workflow4Experimenters, W4E; 
http://workflow4metabolomics.org/events). Such trainings with about 25 participants 
offer unique opportunities to discuss the designs, methods, and tools for 
comprehensive and rigorous data analysis. 
 
In conclusion, the Workflow4Metabolomics 3.0 e-infrastructure provides 
experimenters with unique features to learn, design, run, share, and reference 
comprehensive LC-MS, FIA-MS, GC-MS, and NMR metabolomics data analyses. 
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1. Workflow Management with W4M 
We provide here a brief description of the features offered by the 
Workflow4Metabolomics 3.0 online infrastructure (e-infrastructure). Some of these 
features, such as the building and sharing of workflows and histories, are provided 
by the Galaxy environment, which is used internally by W4M (Goecks et al., 2010). 
Other features are specific to the e-infrastructure, such as the computational tools 
themselves, the referencing of histories with DOI, the user accounts, the tutorials, 
the help desk, and the practical training sessions. 
1.1. User Accounts 
Accounts can be requested on the W4M home page. Accounts are private (i.e., only 
accessible to the user via his/her credentials). 
1.2. Data Format 
1.2.1. Raw data (for preprocessing tools) 
1.2.1.1. MS 
MS data should be in either the mzML, mzXML, mzData, or NetCDF open format 
(Smith et al., 2006). We recommend the use of centroid data, in order to reduce file 
size. Conversion of raw data from proprietary format to centroid open format should 
be performed by the user before upload into W4M, e.g., by using the open-source 
ProteoWizard software (Chambers et al., 2012). 
 
Raw files should be organized into a single or multiple folder(s), corresponding to the 
class(es) to be considered during preprocessing. The class information is used in the 
xcms.group tool, through the minfrac argument, to discard features which are not 
detected in a sufficient number of samples in at least one class (Smith et al., 2006). 
Separate classes may correspond to distinct sample types (blank reagent, quality 
control pools), or experimental conditions (treatment; Smith et al., 2006). 
 
Raw files (either in a single or multiple folders) must be zipped before upload (we 
recommend the use of the 7-Zip open source software; http://www.7-zip.org). 
 
For LC-MS, it is also possible now to upload the files individually (i.e., without folders 
and zip file). Within the history, the files must then be grouped as a data collection 
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(Afgan et al., 2016) for further parallel processing by the xcms.xcmsSet tool. The 
use of a data collection therefore speeds up this computer intensive step. After peak 
detection, the collection of xset.RData outputs, together with a sampleMetadata file 
indicating the classes, are merged with the xcms.xcmsSet Merger tool before the 
grouping step (xcms.group). More details about the use of data collection for LC-
MS data preprocessing can be found: 
1) in the following tutorial: 
http://download.workflow4metabolomics.org/docs/170510_galaxy_xcms_dataset_col
lection.m4v 
2) and on the ‘W4M_sacurine-subset_parallel-preprocessing’ public history: 
https://galaxy.workflow4metabolomics.org/history/list_published 
1.2.1.2. NMR 
NMR preprocessing tools currently work with Bruker files. Each sample directory 
should be organized with acquisition run and process numbered “1” (Table 1 and 
Fig. 8; upper right). Sample directories should then be gathered in a single parent 
directory, which should in turn be zipped before upload into W4M. 
1.2.2. Preprocessed data (for normalization, quality control, 
statistical analysis, and annotation tools) 
Preprocessing of the sample raw files generates a unique sample by variable data 
matrix of peak intensities, in addition to metadata of samples (e.g., sample ID, factor 
of interest) and variables (e.g., m/z and retention time). Such data and metadata are 
handled in W4M in a unique format consisting of 3 separate tables: dataMatrix, 
sampleMetadata, and variableMetadata. These tables, in a tabulated format (e.g., 
.tsv), are generated by the preprocessing tools from W4M, but can also be created 
or modified with spreadsheet editors (such as the Excel or the OpenOffice Calc 
software). The “3 table” format is used in all tools following the preprocessing (i.e., all 
tools for normalization, quality control, statistical analysis, and annotation). Details 
about the formats of the 3 tables can be found in the online tutorials (HowTo section 
from the front page). Once uploaded into W4M with the Upload File tool, the formats 
of the 3 tables can be verified with the Check Format tool (Data Handling section; 
note that the ‘search tools’ feature on top of the ‘Tools’ panel is helpful for locating a 
specific tool). 
1.3. Data Upload 
The Upload File tool allows data upload from a local computer into the W4M 
infrastructure. For sizes up to 2 GB (e.g., NMR raw zip or preprocessed data and 
metadata tables), files can be selected with a simple drag and drop. For bigger data 
sets (e.g., LC-MS and GC-MS raw zip), an FTP client software is required (such as 
Cyberduck, https://cyberduck.io, or WinSCP, https://winscp.net) to directly connect to 
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the ftp://workflow4metabolomics.org infrastructure (with your W4M credentials) and 
copy/paste the zip file (see the Galaxy Initiation tutorial in the HowTo section). 
1.4. Building Workflows 
The user-friendly Galaxy features within the W4M e-infrastructure allow to build and 
save complex workflows. Workflows can be built de novo by using the canvas 
(editor): tools can be chained, and parameter values can be selected. Alternatively, 
workflows can be extracted from an existing history with the Extract workflow option 
(e.g., when the tools have been sequentially tuned on specific data). 
 
1.5. Running Workflows 
W4M offers users a high-performance environment for computing (4,000 cores) and 
data storage. The infrastructure can be accessed via a simple web browser and 
does not consume local resources. Once jobs are launched, the computation will 
continue and the results will be saved, even if the local connection is switched off by 
the user. 
1.6. Sharing Histories 
Histories can be shared with a dedicated user by using his/her W4M email (e.g., with 
colleagues within a lab or a consortium, or with a member from the help desk). 
Alternatively, histories can be published online to give all users unrestricted access 
to the workflow and the associated data (e.g., for training or citation purposes, see 
below). 
1.7. Referencing Histories 
Histories (workflow and all associated input and output data and metadata) can now 
be published on W4M 3.0 with a reference ID and a permanent Digital Object 
Identifier (DOI; see the Result section). Reference histories can then be cited in 
publications (see for instance Rinaudo et al., 2016), thus giving reviewers and 
readers full access to the analysis (i.e., data, metadata, workflow, parameters, and 
results). 
1.8. Tutorials 
Tutorials for data preparation, upload, and analysis, in addition to history sharing and 
publishing, are available in the HowTo section from the front page 
(http://workflow4metabolomics.org). 
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1.9. Help desk 
For any question regarding the features of the infrastructure, the help desk is 
available at support@workflow4metabolomics.org. 
 
2. Case Studies workflows 
For each reference workflow designed for the three case studies, the tools, 
parameter values, and critical points are described hereafter. Histories can be 
accessed via the corresponding DOI permanent link, and imported into the user 
account with Import history followed by start using this history. Workflows can then 
be extracted by selecting Extract workflow from the History options menu. 
2.1 Table S1: W4M00002_Sacurine-comprehensive 
(DOI:10.15454/1.481114233733302E12). 
Please note that the statistical steps are identical to the W4M00001_Sacurine-statistics 
workflow. 
Tool Step Parameters 
(non-default 
values) 
Variables Critical points 
Upload File Data upload 
(negative 
ionization mode; 2 
batches; 24 
blanks + 26 QCs 
+ 184 samples = 
234 files; mzML 
format; centroid; 
17.6 GB) 
  File splitting between 
subfolders impacts 
xcms.group (minfrac 
parameter) 
xcms.xcmsset Peak detection 
within each file 
centWave: 
ppm = 3, 
peakwidth = 
c(5,20), 
snthresh = 10, 
mzdiff = 0.01, 
prefilter = 
c(3,5000), 
noise = 1000 
 
[Original 
matchedFilter 
parameters: 
step = 0.01, 
 Check the Total Ion 
Chromatogram (TIC) and 
Base Peak 
Chromatogram (BPC) 
graphical outputs, 
displayed as pairwise 
comparisons between the 
classes; 
See also the ‘1.2.1.1 Data 
Format’ for parallel 
processing of the files (as 
a ‘data collection’) 
6 
 
fwhm = 4, 
snthresh = 3] 
xcms.group Peak grouping 
between samples 
bw = 5, 
minfrac = 0.1, 
mzwid = 0.01 
 Check on the graphical 
output the relevance of 
the selected parameter 
values 
 
Tool Step Parameters Variables Critical points 
xcms.retcor Alignment of 
retention times 
between samples 
extra = 1, 
missing = 40 
 Check on the graphical 
output the number of 
peak groups used for 
alignment, and their even 
distribution along the time 
axis  
xcms.group Peak grouping 
between samples 
bw = 5, 
minfrac = 0.1, 
mzwid = 0.01 
  
xcms.fillPeaks Imputation of 
missing values 
 7,456 
(100%) 
 
[4,667 
(100%)] 
 
CAMERA.annotate Annotating 
features which 
may belong to the 
same metabolite 
(isotopes, 
adducts, 
fragments) 
num_digits = 4 
polarity = 
negative 
 Select the appropriate 
polarity 
Upload File Import of the 
sampleMetadata 
file which contains 
the sampleType, 
injectionOrder, 
and batch 
columns (to be 
used in the 
Quality Metrics, 
Generic Filter, 
and Batch 
Correction tools), 
osmolality values 
for the 
Normalization 
tool, and age, 
BMI, and gender 
values for the 
Univariate, 
Multivariate, and 
Biosigner 
statistical tools 
   
7 
 
Check Format Checking format 
of dataMatrix, 
sampleMetadata, 
and 
variableMetadata 
files 
   
 
 
Tool Step Parameters Variables Critical points 
Quality Metrics + 
Generic Filter 
Discarding 
variables with: 
1.a) 
blankMean_over_
sampleMean > 
0.5 
or 
1.b) pool_mean < 
0.1 
Discarding blank 
samples 
 6,041 
(81%) 
 
[3,732 
(80%)] 
 
Batch correction Correcting each 
variable for signal 
drift and batch 
effect 
all_loess_pool  Include enough injections 
of the pool sample (at 
least 5 per batch to use 
loess correction), in 
particular at the first and 
last positions; check on 
the graphic if a correction 
is necessary, and which 
kind of model (linear or 
loess) provides the best 
fit 
Quality Metrics + 
Generic Filter 
Discarding 
variables with 
pool_CV > 0.3 
Discarding pool 
samples 
 3,120 
(42%) 
 
[2,102 
(45%)] 
If dilutions of the pool 
sample are provided, the 
correlation with the 
dilution factor is 
computed and can be 
used as an additional 
quality metric 
Normalization Dividing all 
intensities of a 
sample by its 
osmolality value 
   
Transformation  log10   
Univariate Hypothesis testing 
of non-zero 
Spearman 
correlation with 
age or BMI 
(respectively of 
difference of 
medians between 
genders with the 
fdr = 0.05   
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Wilcoxon test), 
including a 
correction for 
multiple testing 
 
 
 
Tool Step Parameters Variables Critical points 
Multivariate OPLS 
(respectively 
OPLS-DA) 
modeling of the 
age or BMI 
response 
(respectively of 
the gender 
response) 
Number of 
orthogonal 
components = 
NA (i.e. 
automatically 
optimized by 
the algorithm) 
 Check the diagnostics; in 
particular the pQ2 value 
obtained after random 
permutation of the labels 
should be <0.05 to avoid 
overfitting 
Biosigner Selection of 
significant 
features for 
building either a 
PLS-DA, Random 
Forest, or SVM 
model of the 
gender response 
Seed = 123  Set a specific seed value 
(Advanced computational 
parameters) to reproduce 
an identical signature 
from the internal 
bootstrap procedure  
HMDB MS search Search the HMDB 
database by the 
ion mz values 
Molecular 
Weight 
Tolerance +- = 
0.001 
Molecular 
Species: 
negative mode 
  
Kegg Compounds Search the KEGG 
database by the 
neutral masses 
Delta of mass 
= 0.001 
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2.2 Table S2: W4M00004_GCMS-Algae 
(DOI:10.15454/1.4811272313071519E12). 
 
Tool Step Parameters 
(non-default 
values) 
Variables Critical points 
Upload File Data upload (12 
.CDF files converted 
from the Agilent 
Chemstation .D 
format) 
  File splitting between 
subfolders impacts 
xcms.group (minfrac 
parameter) 
metaMS.runGC Preprocessing of GC-
MS data 
  Too high 
similarity_threshold value 
might result in some 
compounds with low 
intensity being 
misaligned; check the 
quality of the 
pseudospectra with the 
GCMS_EIC graphical 
output 
Golm 
Metabolome 
Database 
Search the Golm 
Metabolome 
Database with 
spectra in the .msp 
format 
   
For additional database search  
Download 
metaMS result 
Download locally the .msp file for NIST search  
NIST search on 
local computer 
Read the .msp file with your mssearch software (usually preinstalled on your 
GC-MS workstation; for additional information, see the tutorial in the HowTo 
section from the W4M portal) 
Creation of a 
spectral 
database 
Open the peakspectra.msp file; keep Unknowns 2, 4 and 5 only, and set the 
compound names to Citric acid, Mannitol, and Ribitol, respectively; when saving, 
make sure to keep the .msp (or .txt) file extension 
Data re-processing using the user spectral database 
Upload file Upload the modified 
.msp spectra 
database file into 
Galaxy 
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Tool Step Parameters Variables Critical points 
metaMS.runGC Preprocessing of GC-
MS data 
Choose the 
Use personal 
database 
option and 
select your 
modified .msp 
file 
52 
pseudo-
spectra 
 
Normalization Dividing the 
intensities of each 
sample by the dry 
weight value 
   
Multivariate PCA and PLS-DA Scaling = 
pareto, 
transformation 
= Log10 
 Check the diagnostics; for 
PLS models, the pQ2 
value obtained after 
random permutation of 
the labels should be 
<0.05 to avoid overfitting 
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2.3 Table S3: W4M00006_BPAMmusculus 
(DOI:10.15454/1.4821558812795176E12). 
 
Tool Step Parameters 
(non-default 
values) 
Variables Critical points 
Upload data Data upload (24 
samples; Bruker 
format; 7 MB) 
  File name (“1”) of the 
acquisition run and of the 
process of interest impacts 
NMR Bucketing 
NMR 
Bucketing 
Spectra bucketing 
and integration 
BucketWidth = 
0.01 
LeftBorder = 9.5 
RightBorder = 
0.8 
ExclusionZones: 
 Left = 5.1 
 Right = 4.5 
809 
buckets 
Exclusion zones depend on 
the biological matrix and on 
the solvents used to 
prepare the samples 
NMR 
Normalization 
Spectra 
normalization to 
total intensity 
Normalization 
method = Total 
  
Multivariate PCA Scaling = pareto   
Multivariate OPLS-DA modeling 
of the treatment 
response 
Number of 
orthogonal 
components = 
NA (i.e. 
automatically 
optimized by the 
algorithm) 
Scaling = pareto 
 Check the diagnostics; in 
particular the pQ2 value 
obtained after random 
permutation of the labels 
should be <0.05 to avoid 
overfitting 
Generic Filter Discarding variables 
with 
Treatment_OPLSD
A_VIP_pred < 0.8 
 157 
buckets 
 
Univariate Hypothesis testing 
of difference of 
means between 
treatment doses 
with the Wilcoxon 
test and the False 
Discovery Rate 
correction for 
multiple testing 
corrected p-
value 
significance 
threshold = 0.05 
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Tool Step Parameters Variables Critical points 
NMR 
Annotation 
Spectra annotation 
based on an in-
house database 
(175 reference 
compounds) 
ExclusionZones: 
Left = 5.1 
Right = 4.5 
shift = 0.01 
39 
identified 
metabolit
es 
Input spectrum can be a 
pool of all biological 
samples; alternatively, one 
spectrum from each class 
can be annotated; 
Exclusion zones depend on 
the biological matrix and on 
the solvents used to 
prepare the samples 
Identified metabolites 
should be checked by an 
NMR analyst 
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